Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol.

Masatoshi TakagiChitose OgawaYuki Aoki-NogamiTomoko IeharaEri IshibashiMinoru ImaiTetsuro KiharaKiyoshi NoboriKazuhisa HasebeShuki MizutaniToshimi KimuraMasashi NagataMasato YasuharaKenichi YoshimuraPariko YorozuHajime HosoiRyuji Koike

Published in: BMC pediatrics (2019)

UMIN-CTR ( UMIN000025521 ); Registered on January 4, 2017.

Keyphrases

study protocol
randomized controlled trial
double blind
clinical trial
open label
placebo controlled